Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 23, 2023Clinical Gastroenterology and HepatologyOpen Access

Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b Study

View Full Paper
Ask AI
Bookmark
Share

Authors

Rohit LoombaRohit LoombaPediatric CardiologyArun J. SanyalArun J. SanyalUniversity of North Carolina at Chapel HillANAtsushi NakajimaUeno Gakuen University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Loomba et al. (2023) studied this question.

synapsesocial.com/papers/6a7722f5d8eb58afc2bda764https://doi.org/10.1016/j.cgh.2023.04.011
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1Effect of pegbelfermin on NASH and fibrosis-related biomarkers and correlation with histological response in the FALCON 1 trial2023 · 36 citations